B.C. releases latest numbers on biosimilar switches

March 5, 2020

On the surface the number of patients switching to a biosimilar biologic during phase two of the B.C. government’s Biosimilars Initiative, launched in May 2019, appears low; however, a closer look suggests it is too early to draw conclusions.


Share on facebook
Share on twitter
Share on pinterest
Share on linkedin

We’re ready to help. With COVID-19 top of mind, we’re committed to keeping you informed. Learn More